Chemokines
Chemokine Therapeutics on BusinessTV The chemokine network in cancer - much more than directing cell movement THE CXCR4 ANTAGONIST CTCE-9908 INHIBITS SDF-1-INDUCED ANGIOGENESIS Messenger RNAExpression Levels of CXCR4 Correlatewith Metastatic Behavior and Outcome in Patients with Osteosarcoma CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis Chemokine receptor CXCR4-1 integrin axis mediates tumorigenesis of osteosarcoma HOS cells
Ellagic Acid
Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound Low Concentrations of Quercetin and Ellagic Acid Synergistically Influence Proliferation, Cytotoxicity and Apoptosis in MOLT-4 Human Leukemia Cells1–3
mTor Inhibitor
ARIAD REPORTS TUMOR REGRESSION WITH AP23573 AS A SINGLE AGENT IN PATIENTS WITH RELAPSED AND/OR REFRACTORY CANCERAn expanding role for mTOR in cancer
Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma
Rexin-G
About Rexin-G
Valproic Acid
Valproic Acid Inhibits Angiogenesis in Vitro and in Vivo The Histone Deacetylase (HDAC) Inhibitor Valproic Acid as Monotherapy or in Combination with All- Trans Retinoic Acid in Patients with Acute Myeloid Leukemia Valproic Acid defines a novel class of HDAC inhibitors inducing differention f transformed cells Epigenetic therapy of cancer: past, present and future Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Zoledronic Acid
Anticancer Effects of Zoledronic Acid against Human Osteosarcoma Cells